WCH26: Advances and Applications in Chronic Spontaneous Urticaria Care
Released on
January 8, 2026
WCH26: Advances and Applications in Chronic Spontaneous Urticaria Care
This activity is supported by educational grants from Novartis Pharmaceuticals Corporation and Sanofi and Regeneron Pharmaceuticals, Inc.